Cargando…

Pseudoceramide-Containing Physiological Lipid Mixture Reduces Adverse Effects of Topical Steroids

PURPOSE: Various therapeutic approaches have been suggested for preventing or reducing the adverse effects of topical glucocorticoids, including skin barrier impairment. Previously, we have shown that impairment of skin barrier function by the highest potency topical glucocorticoid, clobetasol 17-pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyun Jung, Park, Hyun Jung, Yun, Jae Nam, Jeong, Se Kyoo, Ahn, Sung Ku, Lee, Seung Hun
Formato: Texto
Lenguaje:English
Publicado: The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062802/
https://www.ncbi.nlm.nih.gov/pubmed/21461248
http://dx.doi.org/10.4168/aair.2011.3.2.96
_version_ 1782200744151089152
author Kim, Hyun Jung
Park, Hyun Jung
Yun, Jae Nam
Jeong, Se Kyoo
Ahn, Sung Ku
Lee, Seung Hun
author_facet Kim, Hyun Jung
Park, Hyun Jung
Yun, Jae Nam
Jeong, Se Kyoo
Ahn, Sung Ku
Lee, Seung Hun
author_sort Kim, Hyun Jung
collection PubMed
description PURPOSE: Various therapeutic approaches have been suggested for preventing or reducing the adverse effects of topical glucocorticoids, including skin barrier impairment. Previously, we have shown that impairment of skin barrier function by the highest potency topical glucocorticoid, clobetasol 17-propinate (CP), can be partially prevented by co-application of a physiological lipid mixture containing pseudoceramide, free fatty acids, and cholesterol (multi-lamellar emulsion [MLE]). Skin atrophic effects of CP were also partially reduced by MLE. In this study, the preventive effects of MLE on the lowest potency topical glucocorticoid, hydrocortisone (HC), were investigated using animal models. METHODS: Anti-inflammatory activity of topical HC was evaluated using a 12-O-tetradecanoylphobol-13-acetate-induced skin edema model. Topical steroid induced adverse effects were evaluated using hairless mouse. RESULTS: The results showed that the anti-inflammatory activity was not altered by co-application of either MLE or hydrobase. However, co-application of MLE and 1.0% HC showed less impairment in the epidermal permeability barrier function, skin hydration, and skin surface pH compared with hydrobase. Stratum corneum integrity, evaluated by measuring trans-epidermal water loss after repeated tape stripping, showed less damage with MLE co-application. Long-term application of topical HC induced skin atrophy, measured by a reduction in skinfold and epidermal thickness and in the number of epidermal proliferating cell nucleus antigen (PCNA)-positive keratinocytes. Co-application of MLE did not affect the skinfold or epidermal thickness, but the number of PCNA-positive keratinocytes was less decreased with MLE use. CONCLUSIONS: These results suggest that co-application of MLE is effective in reducing the local adverse effects of low-potency topical glucocorticoids and supports the therapeutic efficacy of physiological lipid mixtures on skin barrier function.
format Text
id pubmed-3062802
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
record_format MEDLINE/PubMed
spelling pubmed-30628022011-04-01 Pseudoceramide-Containing Physiological Lipid Mixture Reduces Adverse Effects of Topical Steroids Kim, Hyun Jung Park, Hyun Jung Yun, Jae Nam Jeong, Se Kyoo Ahn, Sung Ku Lee, Seung Hun Allergy Asthma Immunol Res Original Article PURPOSE: Various therapeutic approaches have been suggested for preventing or reducing the adverse effects of topical glucocorticoids, including skin barrier impairment. Previously, we have shown that impairment of skin barrier function by the highest potency topical glucocorticoid, clobetasol 17-propinate (CP), can be partially prevented by co-application of a physiological lipid mixture containing pseudoceramide, free fatty acids, and cholesterol (multi-lamellar emulsion [MLE]). Skin atrophic effects of CP were also partially reduced by MLE. In this study, the preventive effects of MLE on the lowest potency topical glucocorticoid, hydrocortisone (HC), were investigated using animal models. METHODS: Anti-inflammatory activity of topical HC was evaluated using a 12-O-tetradecanoylphobol-13-acetate-induced skin edema model. Topical steroid induced adverse effects were evaluated using hairless mouse. RESULTS: The results showed that the anti-inflammatory activity was not altered by co-application of either MLE or hydrobase. However, co-application of MLE and 1.0% HC showed less impairment in the epidermal permeability barrier function, skin hydration, and skin surface pH compared with hydrobase. Stratum corneum integrity, evaluated by measuring trans-epidermal water loss after repeated tape stripping, showed less damage with MLE co-application. Long-term application of topical HC induced skin atrophy, measured by a reduction in skinfold and epidermal thickness and in the number of epidermal proliferating cell nucleus antigen (PCNA)-positive keratinocytes. Co-application of MLE did not affect the skinfold or epidermal thickness, but the number of PCNA-positive keratinocytes was less decreased with MLE use. CONCLUSIONS: These results suggest that co-application of MLE is effective in reducing the local adverse effects of low-potency topical glucocorticoids and supports the therapeutic efficacy of physiological lipid mixtures on skin barrier function. The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2011-04 2011-02-14 /pmc/articles/PMC3062802/ /pubmed/21461248 http://dx.doi.org/10.4168/aair.2011.3.2.96 Text en Copyright © 2011 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kim, Hyun Jung
Park, Hyun Jung
Yun, Jae Nam
Jeong, Se Kyoo
Ahn, Sung Ku
Lee, Seung Hun
Pseudoceramide-Containing Physiological Lipid Mixture Reduces Adverse Effects of Topical Steroids
title Pseudoceramide-Containing Physiological Lipid Mixture Reduces Adverse Effects of Topical Steroids
title_full Pseudoceramide-Containing Physiological Lipid Mixture Reduces Adverse Effects of Topical Steroids
title_fullStr Pseudoceramide-Containing Physiological Lipid Mixture Reduces Adverse Effects of Topical Steroids
title_full_unstemmed Pseudoceramide-Containing Physiological Lipid Mixture Reduces Adverse Effects of Topical Steroids
title_short Pseudoceramide-Containing Physiological Lipid Mixture Reduces Adverse Effects of Topical Steroids
title_sort pseudoceramide-containing physiological lipid mixture reduces adverse effects of topical steroids
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062802/
https://www.ncbi.nlm.nih.gov/pubmed/21461248
http://dx.doi.org/10.4168/aair.2011.3.2.96
work_keys_str_mv AT kimhyunjung pseudoceramidecontainingphysiologicallipidmixturereducesadverseeffectsoftopicalsteroids
AT parkhyunjung pseudoceramidecontainingphysiologicallipidmixturereducesadverseeffectsoftopicalsteroids
AT yunjaenam pseudoceramidecontainingphysiologicallipidmixturereducesadverseeffectsoftopicalsteroids
AT jeongsekyoo pseudoceramidecontainingphysiologicallipidmixturereducesadverseeffectsoftopicalsteroids
AT ahnsungku pseudoceramidecontainingphysiologicallipidmixturereducesadverseeffectsoftopicalsteroids
AT leeseunghun pseudoceramidecontainingphysiologicallipidmixturereducesadverseeffectsoftopicalsteroids